West Oak Capital’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-118
Closed -$12.5K 347
2018
Q1
$12.5K Hold
118
0.01% 258
2017
Q4
$13.9K Hold
118
0.01% 234
2017
Q3
$13.5K Sell
118
-37
-24% -$4.27K 0.01% 262
2017
Q2
$19.3K Hold
155
0.01% 240
2017
Q1
$18.3K Sell
155
-133
-46% -$15.1K 0.01% 253
2016
Q4
$28.9K Sell
288
-134
-32% -$14.4K 0.02% 222
2016
Q3
$53.3K Buy
422
+134
+47% +$16.6K 0.04% 172
2016
Q2
$33.7K Hold
288
0.02% 192
2016
Q1
$29.9K Hold
288
0.02% 169
2015
Q4
$28.7K Hold
288
0.02% 171
2015
Q3
$26.3K Hold
288
0.02% 173
2015
Q2
$30.6K Hold
288
0.02% 169
2015
Q1
$32.9K Hold
288
0.02% 173
2014
Q4
$31.8K Hold
288
0.02% 180
2014
Q3
$28.2K Hold
288
0.02% 165
2014
Q2
$29.1K Hold
288
0.02% 169
2014
Q1
$26.5K Hold
288
0.02% 172
2013
Q4
$26.1K Hold
288
0.02% 175
2013
Q3
$23K Hold
288
0.02% 175
2013
Q2
$21K Buy
+288
New +$21.5K 0.02% 173

Other funds holding ZBH

West Oak Capital's ZBH Position: Q2 2018 in Review

West Oak Capital sold out of Zimmer Biomet (ZBH) in Q2 2018, closing a stake of 118 shares — an estimated $12.5K sold.

West Oak Capital first reported a position in ZBH in Q2 2013 and held it in 20 quarters. The position peaked at $53.3K in Q3 2016. 869 funds tracked by Wall St. Rank hold ZBH as of Q2 2018.

  • West Oak Capital reported no remaining Zimmer Biomet position as of Q2 2018 after selling out during the quarter.
  • West Oak Capital sold 118 Zimmer Biomet shares in Q2 2018, an estimated $12.5K.
  • West Oak Capital first reported a position in Zimmer Biomet in Q2 2013 and held it in 20 quarters.
  • West Oak Capital's Zimmer Biomet position peaked at $53.3K in Q3 2016.
  • 869 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2018.

Based on West Oak Capital's 13F filing for Q2 2018, filed 6 Jul 2018.